{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:41:49Z","timestamp":1793680909253,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The vast majority of tumours in the sellar region are pituitary neuroendocrine tumours, also called pituitary adenomas. Sellar gangliocytomas (GCs), benign tumours that originate from neuronal ganglionic cells, account for less than 1% of sellar tumours. Even rarer are mixed gangliocytoma-pituitary neuroendocrine tumours (GC-PitNET). These tumours are often associated with hormone hypersecretion, most commonly resulting in acromegaly. The histogenesis of mixed GC\u2013PitNET is currently unclear. In this paper, we present comprehensive clinical, immunohistochemical, targeting enrichment next generation DNA sequencing, and genome-wide methylation data from four patients with mixed GC-PitNETs, three with acromegaly and one with Cushing\u2019s disease. Transcriptomic data are also included for two of the patients. Our findings indicate that mixed GC-PitNETs have different clinical course, with the acromegaly patients showing greater resistance to pharmacological therapy, as well as different protein expression and molecular features compared to respective pure PitNETs. The transcriptomic data on two patients with somatotroph GC-PitNET show involvement of mitochondrial and ribosomal genes, suggesting a distinct gene expression pattern, in comparison with pure somatotroph tumours. Furthermore, the expression pattern of selected stem cell markers, mainly SOX9, supports a common origin of the neuroendocrine and ganglionic tumour components, suggesting the involvement of stem cells in tumorigenesis.<\/jats:p>","DOI":"10.1186\/s40478-026-02225-x","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:13:58Z","timestamp":1769793238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mixed gangliocytoma-pituitary neuroendocrine tumour: clinical, immunohistochemical, and molecular genetic profiles in a series of four patients"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0138-0178","authenticated-orcid":false,"given":"Konstantinos","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-5193","authenticated-orcid":false,"given":"Britt Ed\u00e9n","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-2678","authenticated-orcid":false,"given":"Abdellah","family":"Tebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Olsson","family":"Bontell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1727-1389","authenticated-orcid":false,"given":"Alice","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Nord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Lindskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning B\u00fcnsow","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-9492","authenticated-orcid":false,"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7376-7331","authenticated-orcid":false,"given":"Olivera","family":"Casar-Borota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"12 Suppl 2","key":"2225_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neuro Oncol 23(12 Suppl 2):iii1\u2013iii105","journal-title":"Neuro Oncol"},{"key":"2225_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clineuro.2016.08.002","volume":"149","author":"G Cossu","year":"2016","unstructured":"Cossu G, Daniel RT, Messerer M (2016) Gangliocytomas of the sellar region: a challenging diagnosis. Clin Neurol Neurosurg 149:122\u2013135","journal-title":"Clin Neurol Neurosurg"},{"key":"2225_CR3","unstructured":"WHO Classification of Tumours Editorial Board (2022) Endocrine and neuroendocrine tumours. Lyon (France): International Agency for Research on Cancer; WHO classification of tumour series, 5th ed.; vol 10. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/53"},{"key":"2225_CR4","volume-title":"World health organization classification of tumours of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J (2017) World health organization classification of tumours of endocrine organs, 4th edn. IARC, Lyon","edition":"4"},{"issue":"10","key":"2225_CR5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00701-018-3632-7","volume":"160","author":"B Yang","year":"2018","unstructured":"Yang B, Yang C, Sun Y, Du J, Liu P, Jia G et al (2018) Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience. Acta Neurochir (Wien) 160(10):1989\u20131999","journal-title":"Acta Neurochir (Wien)"},{"key":"2225_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.wneu.2024.10.051","volume":"193","author":"K Balasubramanian","year":"2025","unstructured":"Balasubramanian K, Andrade de Almeida RA, Kharbat AF, Haider AS, Dunn IF, Graffeo CS (2025) Mixed gangliocytoma-pituitary adenoma: a systematic review of diagnostic features, clinical management, and surgical outcomes. World Neurosurg 193:754\u2013769","journal-title":"World Neurosurg"},{"issue":"4","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s42000-022-00392-9","volume":"21","author":"JV Sch\u00f6ning","year":"2022","unstructured":"Sch\u00f6ning JV, Flitsch J, L\u00fcdecke DK, Fahlbusch R, Buchfelder M, Buslei R et al (2022) Multiple tumorous lesions of the pituitary gland. Hormones (Athens) 21(4):653\u2013663","journal-title":"Hormones (Athens)"},{"key":"2225_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.wneu.2017.08.174","volume":"108","author":"MJ Shepard","year":"2017","unstructured":"Shepard MJ, Elzoghby MA, Ghanim D, Lopes MBS, Jane Jr JA (2017) Transsphenoidal surgery for mixed pituitary gangliocytoma-adenomas. World Neurosurg 108:310\u2013316","journal-title":"World Neurosurg"},{"issue":"9","key":"2225_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jnen\/nlae050","volume":"83","author":"BK Kleinschmidt-DeMasters","year":"2024","unstructured":"Kleinschmidt-DeMasters BK (2024) Mixed pituitary adenoma\/pituitary neuroendocrine tumor-gangliocytoma: immunohistochemical insights. J Neuropathol Exp Neurol 83(9):708\u2013721","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2225_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","volume":"76","author":"SL Fougner","year":"2012","unstructured":"Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) 76(1):96\u2013102","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2225_CR11","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1210\/jc.2012-2609","volume":"98","author":"F Gatto","year":"2013","unstructured":"Gatto F, Feelders RA, van der Pas R, Kros JM, Waaijers M, Sprij-Mooij D et al (2013) Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metab 98(1):E66\u201371","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2225_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1210\/jc.2018-01524","volume":"104","author":"A Muhammad","year":"2019","unstructured":"Muhammad A, Coopmans EC, Gatto F, Franck SE, Janssen J, van der Lely AJ et al (2019) Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression. J Clin Endocrinol Metab 104(3):915\u2013924","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2225_CR13","doi-asserted-by":"publisher","first-page":"E1730","DOI":"10.1210\/jc.2013-2145","volume":"98","author":"O Casar-Borota","year":"2013","unstructured":"Casar-Borota O, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T et al (2013) Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide. J Clin Endocrinol Metab 98(11):E1730\u2013E1739","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2225_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00705811","volume":"52","author":"SL Asa","year":"1980","unstructured":"Asa SL, Bilbao JM, Kovacs K, Linfoot JA (1980) Hypothalamic neuronal Hamartoma associated with pituitary growth hormone cell adenoma and acromegaly. Acta Neuropathol 52(3):231\u2013234","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2225_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/01913129409021900","volume":"18","author":"E Horvath","year":"1994","unstructured":"Horvath E, Kovacs K, Scheithauer BW, Lloyd RV, Smyth HS (1994) Pituitary adenoma with neuronal choristoma (PANCH): Composite lesion or lineage infidelity? Ultrastruct Pathol 18(6):565\u2013574","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"2225_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-006-0055-y","volume":"112","author":"G Kontogeorgos","year":"2006","unstructured":"Kontogeorgos G, Mourouti G, Kyrodimou E, Liapi-Avgeri G, Parasi E (2006) Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells. Acta Neuropathol 112(1):21\u201328","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2225_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.yexmp.2015.11.004","volume":"99","author":"MT Nguyen","year":"2015","unstructured":"Nguyen MT, Lavi E (2015) Pituitary adenoma-neuronal choristoma is a pituitary adenoma with ganglionic differentiation. Exp Mol Pathol 99(3):628\u2013631","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"2225_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/PAS.0000000000000806","volume":"41","author":"MB Lopes","year":"2017","unstructured":"Lopes MB, Sloan E, Polder J (2017) Mixed gangliocytoma-pituitary adenoma: insights on the pathogenesis of a rare sellar tumor. Am J Surg Pathol 41(5):586\u2013595","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2225_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21873\/invivo.11442","volume":"33","author":"C Capatina","year":"2019","unstructured":"Capatina C, Cimpean AM, Raica M, Coculescu M, Poiana C (2019) SOX 2 expression in human pituitary adenomas-correlations with pituitary function. In Vivo 33(1):79\u201383","journal-title":"In Vivo"},{"issue":"1","key":"2225_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12902-021-00720-x","volume":"21","author":"FI Shirian","year":"2021","unstructured":"Shirian FI, Ghorbani M, Khamseh ME, Imani M, Panahi M, Alimohammadi A et al (2021) Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas. BMC Endocr Disord 21(1):50","journal-title":"BMC Endocr Disord"},{"key":"2225_CR21","unstructured":"\u00d8ystese KA, Olarescu NC, Lindskog C, Xheka F, Berg-Johnsen J, Berg JP et al (2024) Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours. Free Neuropathol 5:5\u201314"},{"issue":"1","key":"2225_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40478-021-01284-6","volume":"9","author":"A Tebani","year":"2021","unstructured":"Tebani A, Jotanovic J, Hekmati N, Sivertsson A, Gudjonsson O, Eden Engstrom B et al (2021) Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis. Acta Neuropathol Commun 9(1):181","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2225_CR23","doi-asserted-by":"publisher","first-page":"19373","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"Taniguchi-Ponciano K, Andonegui-Elguera S, Pena-Martinez E, Silva-Roman G, Vela-Patino S, Gomez-Apo E et al (2020) Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep 10(1):19373","journal-title":"Sci Rep"},{"issue":"1","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37(1):123\u2013134 e5","journal-title":"Cancer Cell"},{"issue":"8","key":"2225_CR25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/neuonc\/noab044","volume":"23","author":"MS Mosella","year":"2021","unstructured":"Mosella MS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP et al (2021) DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro Oncol 23(8):1292\u20131303","journal-title":"Neuro Oncol"},{"issue":"17","key":"2225_CR26","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Wang X, Marzese DM, Hsu SC, Nelson N, Zhang X et al (2018) The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, cushing\u2019s disease and endocrine-inactive subtypes. Clin Cancer Res 24(17):4126\u20134136","journal-title":"Clin Cancer Res"},{"key":"2225_CR27","doi-asserted-by":"crossref","unstructured":"Sill M, Schrimpf D, Patel A, Sturm D, J\u00e4ger N, Sievers P et al (2025) Advancing CNS tumor diagnostics with expanded DNA methylation-based classification. MedRxiv. 2025.05.28.25328344.","DOI":"10.1101\/2025.05.28.25328344"},{"issue":"2","key":"2225_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF02478929","volume":"19","author":"M Kurosaki","year":"2002","unstructured":"Kurosaki M, Saeger W, Ludecke DK (2002) Intrasellar gangliocytomas associated with acromegaly. Brain Tumor Pathol 19(2):63\u201367","journal-title":"Brain Tumor Pathol"},{"key":"2225_CR29","doi-asserted-by":"crossref","unstructured":"Coopmans EC, Korevaar TIM, van Meyel SWF, Daly AF, Chanson P, Brue T et al (2020) Multivariable prediction model for biochemical response to first-generation somatostatin receptor ligands in acromegaly. J Clin Endocrinol Metab 105(9):2964\u20132974","DOI":"10.1210\/clinem\/dgaa387"},{"key":"2225_CR30","doi-asserted-by":"crossref","unstructured":"Akirov A, Asa SL, Amer L, Shimon I, Ezzat S (2019) The clinicopathological spectrum of acromegaly. J Clin Med 8(11):1962","DOI":"10.3390\/jcm8111962"},{"issue":"11","key":"2225_CR31","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1210\/jc.2005-0998","volume":"90","author":"S Bhayana","year":"2005","unstructured":"Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S (2005) The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 90(11):6290\u20136295","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2225_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2265.2007.03065.x","volume":"68","author":"SL Fougner","year":"2008","unstructured":"Fougner SL, Borota OC, Berg JP, Hald JK, Ramm-Pettersen J, Bollerslev J (2008) The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma. Clin Endocrinol (Oxf) 68(3):458\u2013465","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2225_CR33","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1210\/clinem\/dgaa474","volume":"105","author":"K Sakata","year":"2020","unstructured":"Sakata K, Fujimori K, Komaki S, Furuta T, Sugita Y, Ashida K et al (2020) Pituitary gangliocytoma producing TSH and TRH: a review of gangliocytomas of the sellar region. J Clin Endocrinol Metab 105(10):3109\u20133121","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2225_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000448429","volume":"105","author":"SE Franck","year":"2017","unstructured":"Franck SE, Gatto F, van der Lely AJ, Janssen J, Dallenga AHG, Nagtegaal AP et al (2017) Somatostatin receptor expression in GH-secreting pituitary adenomas treated with long-acting somatostatin analogues in combination with pegvisomant. Neuroendocrinology 105(1):44\u201353","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2225_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/PAS.0000000000000803","volume":"41","author":"C Sergeant","year":"2017","unstructured":"Sergeant C, Jublanc C, Leclercq D, Boch AL, Bielle F, Raverot G et al (2017) Transdifferentiation of neuroendocrine cells: gangliocytoma associated with two pituitary adenomas of different lineage in MEN1. Am J Surg Pathol 41(6):849\u2013853","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2225_CR36","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","volume":"54","author":"R Wurth","year":"2017","unstructured":"Wurth R, Barbieri F, Pattarozzi A, Gaudenzi G, Gatto F, Fiaschi P et al (2017) Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas. Mol Neurobiol 54(7):4879\u20134895","journal-title":"Mol Neurobiol"},{"key":"2225_CR37","doi-asserted-by":"crossref","unstructured":"Kozakiewicz P, Grzybowska-Szatkowska L, Ciesielka M, Calka P, Osuchowski J, Szmygin P et al (2022) Mitochondrial DNA changes in genes of respiratory complexes III, IV and V could be related to brain tumours in humans. Int J Mol Sci 23(20):12131","DOI":"10.3390\/ijms232012131"},{"issue":"1","key":"2225_CR38","doi-asserted-by":"publisher","first-page":"15716","DOI":"10.1038\/s41598-019-51951-x","volume":"9","author":"GC Cavalcante","year":"2019","unstructured":"Cavalcante GC, Marinho ANR, Anaissi AK, Vinasco-Sandoval T, Ribeiro-Dos-Santos A, Vidal AF et al (2019) Whole mitochondrial genome sequencing highlights mitochondrial impact in gastric cancer. Sci Rep 9(1):15716","journal-title":"Sci Rep"},{"key":"2225_CR39","doi-asserted-by":"crossref","unstructured":"de Oliveira RC, Dos Reis SP, Cavalcante GC (2023) Mutations in structural genes of the mitochondrial complex IV May influence breast cancer. Genes (Basel). 14(7):1465","DOI":"10.3390\/genes14071465"},{"issue":"9","key":"2225_CR40","first-page":"2768","volume":"10","author":"C Zhou","year":"2020","unstructured":"Zhou C, Weng J, Liu C, Zhou Q, Chen W, Hsu JL et al (2020) High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Am J Cancer Res 10(9):2768\u20132784","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2225_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/cam4.4848","volume":"12","author":"AH Fan","year":"2023","unstructured":"Fan AH, Zhao X, Liu H, Li D, Guo T, Zhang J et al (2023) eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients. Cancer Med 12(1):513\u2013524","journal-title":"Cancer Med"},{"issue":"3","key":"2225_CR42","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/jcp.30010","volume":"236","author":"W Geng","year":"2021","unstructured":"Geng W, Ren J, Shi H, Qin F, Xu X, Xiao S et al (2021) RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation. J Cell Physiol 236(3):2214\u20132225","journal-title":"J Cell Physiol"},{"issue":"2","key":"2225_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136(2):181\u2013210","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02225-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:04:27Z","timestamp":1771959867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02225-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02225-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study on the tissue material from patients operated on for pituitary tumours at Uppsala and Gothenburg University Hospital has been approved by The Regional Ethical Review Authority in Uppsala, Dnr 2018\/053, respectively Gothenburg, Dnr 814\/18.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}